Lineage Cell Therapeutics Inc.
LCTX | AMEX
$1.04
+$0.03 (+2.97%)
At close: Sep 22, 2026, 4:00 PM ET
$1.03
-$0.01 (-0.95%)
After-hours:
Sep 22, 2026, 6:49 PM ET
Institutional Ownership
Net InflowTotal Institutions
132
Total Ownership
45.58%
Capital Flow
+$6.71M
Shares Change
+10.03M
Ownership Distribution
Institutions (45.58%)
Others (54.42%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
bullishNew Positions
25
Increased Positions
60
Reduced Positions
27
Closed Positions
17
New (25)
Increased (60)
Reduced (27)
Closed (17)
Options Sentiment & Activity
bullishPut/Call Ratio
0.189
Call Flow
115,100
Put Flow
21,800
Calls (84%)
Puts (16%)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Point72 Asset Management LP | 0.12% +90.93% | < 0.01% | 304.36K | 319.58K |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Broadwood Capital Inc | 20.23% -6.09% | 5.52% +13.51% | 49.56M 0.00% | 78.31M -5.39% | |
| Vanguard Capital Management LLC | 3.40% +100.00% | < 0.01% +100.00% | 8.32M +100.00% | 13.14M +100.00% | |
| Defender Capital, Llc. | 2.75% -7.45% | 3.77% +2.07% | 6.73M -1.46% | 10.63M -6.77% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove LCTX